Difference between revisions of "Timeline of HIV/AIDS"
From Timelines
Line 32: | Line 32: | ||
|- | |- | ||
| 1969 || May || Notable death || 16-year-old African-American {{w|Robert Rayford}} dies at the St. Louis City Hospital from {{w|Kaposi's sarcoma}}. In 1987 researchers at Tulane University School of Medicine would detect "a virus closely related or identical to" HIV-1 in his preserved blood and tissues.<ref name=Garry88>{{cite journal | vauthors = Garry RF, Witte MH, Gottlieb AA, Elvin-Lewis M, Gottlieb MS, Witte CL, Alexander SS, Cole WR, Drake WL | title = Documentation of an AIDS virus infection in the United States in 1968 | journal = JAMA | volume = 260 | issue = 14 | pages = 2085–7 | date = October 1988 | pmid = 3418874 | doi = 10.1001/jama.1988.03410140097031 }}</ref><ref>{{cite conference |url=http://www.tulane.edu/~dmsander/Abstracts/rr99.html |archiveurl=https://web.archive.org/web/20070415000000/http://www.tulane.edu/~dmsander/Abstracts/rr99.html |archivedate=2007-04-15 |title=The Earliest Known AIDS Patient in the United States was Infected with an HIV-1 Strain Closely Related to IIIB/LAI |vauthors=Haislip AM, Witte MH, Sullivan KA, Wolfe M, Gottlieb AA, Gottlieb MS, Cole WR, Witte CL, Garry RF |booktitle=XIth International Congress of Virology, Sydney Convention Center, Australia, 9–13 August 1999 }}</ref><ref>{{cite web|url=http://hivinsite.ucsf.edu/InSite?page=kb-01-03|title=Epidemiology of HIV/AIDS in the United States|work=ucsf.edu|accessdate=21 March 2018}}</ref><ref>{{cite news|first=Gina|last=Kolata|url = https://query.nytimes.com/gst/fullpage.html?res=9B0DEFD6173AF93BA15753C1A961948260&sec=health&pagewanted=all|title=Boy's 1969 death suggests AIDS invaded U.S. Several times|work=The New York Times|date=1987-10-28}}</ref> | | 1969 || May || Notable death || 16-year-old African-American {{w|Robert Rayford}} dies at the St. Louis City Hospital from {{w|Kaposi's sarcoma}}. In 1987 researchers at Tulane University School of Medicine would detect "a virus closely related or identical to" HIV-1 in his preserved blood and tissues.<ref name=Garry88>{{cite journal | vauthors = Garry RF, Witte MH, Gottlieb AA, Elvin-Lewis M, Gottlieb MS, Witte CL, Alexander SS, Cole WR, Drake WL | title = Documentation of an AIDS virus infection in the United States in 1968 | journal = JAMA | volume = 260 | issue = 14 | pages = 2085–7 | date = October 1988 | pmid = 3418874 | doi = 10.1001/jama.1988.03410140097031 }}</ref><ref>{{cite conference |url=http://www.tulane.edu/~dmsander/Abstracts/rr99.html |archiveurl=https://web.archive.org/web/20070415000000/http://www.tulane.edu/~dmsander/Abstracts/rr99.html |archivedate=2007-04-15 |title=The Earliest Known AIDS Patient in the United States was Infected with an HIV-1 Strain Closely Related to IIIB/LAI |vauthors=Haislip AM, Witte MH, Sullivan KA, Wolfe M, Gottlieb AA, Gottlieb MS, Cole WR, Witte CL, Garry RF |booktitle=XIth International Congress of Virology, Sydney Convention Center, Australia, 9–13 August 1999 }}</ref><ref>{{cite web|url=http://hivinsite.ucsf.edu/InSite?page=kb-01-03|title=Epidemiology of HIV/AIDS in the United States|work=ucsf.edu|accessdate=21 March 2018}}</ref><ref>{{cite news|first=Gina|last=Kolata|url = https://query.nytimes.com/gst/fullpage.html?res=9B0DEFD6173AF93BA15753C1A961948260&sec=health&pagewanted=all|title=Boy's 1969 death suggests AIDS invaded U.S. Several times|work=The New York Times|date=1987-10-28}}</ref> | ||
+ | |- | ||
+ | | 1971 || || Test || The {{w|enzyme-linked immunosorbent assay}} (ELISA) is introduced by Swedish immunologist Peter Perlmann and {{w|Eva Engvall}} at {{w|Stockholm University}} in Sweden, as a test that uses antibodies and color change to identify a substance. ELISA would later be used for the detection of HIV antibodies in blood samples.<ref>{{cite book |last1=Corley |first1=Ronald B. |title=A Guide to Methods in the Biomedical Sciences |url=https://books.google.com.ar/books?id=a2lCg_BaA04C&pg=PA79&dq=%22elisa%22+%22in+1971%22&hl=en&sa=X&ved=0ahUKEwizj7C2xbDbAhUHmJAKHaWgDkUQ6AEIMDAB#v=onepage&q=%22elisa%22%20%22in%201971%22&f=false}}</ref><ref>{{cite book |last1=Owusu-Apenten |first1=Richard |title=Food Protein Analysis: Quantitative Effects On Processing |url=https://books.google.com.ar/books?id=ArXJlJfl0gMC&pg=PA218&dq=%22elisa%22+%22in+1971%22&hl=en&sa=X&ved=0ahUKEwizj7C2xbDbAhUHmJAKHaWgDkUQ6AEIRjAF#v=onepage&q=%22elisa%22%20%22in%201971%22&f=false}}</ref><ref>{{cite web |title=ELISA- Principle, Types and Applications |url=http://www.microbiologynotes.com/elisa-principle-types-and-applications/ |website=microbiologynotes.com |accessdate=31 May 2018}}</ref> | ||
|- | |- | ||
| 1972–1973 || || Infection || Researchers draw blood from 75 children in {{w|Uganda}} to serve as controls for a study of {{w|Burkitt's lymphoma}}. In 1985, retroactive testing of the frozen blood serum indicate that antibodies to a virus related to HIV are present in 50 of the children.<ref>{{cite journal | vauthors = Saxinger WC, Levine PH, Dean AG, de Thé G, Lange-Wantzin G, Moghissi J, Laurent F, Hoh M, Sarngadharan MG, Gallo RC | title = Evidence for exposure to HTLV-III in Uganda before 1973 | journal = [[Science (journal)|Science]] | volume = 227 | issue = 4690 | pages = 1036–1038 | date = March 1985 | pmid = 2983417 | doi = 10.1126/science.2983417 | url = http://www.epiinformatics.com/ADPublications/HTLV1Antibodies.pdf | bibcode = 1985Sci...227.1036S }}</ref> | | 1972–1973 || || Infection || Researchers draw blood from 75 children in {{w|Uganda}} to serve as controls for a study of {{w|Burkitt's lymphoma}}. In 1985, retroactive testing of the frozen blood serum indicate that antibodies to a virus related to HIV are present in 50 of the children.<ref>{{cite journal | vauthors = Saxinger WC, Levine PH, Dean AG, de Thé G, Lange-Wantzin G, Moghissi J, Laurent F, Hoh M, Sarngadharan MG, Gallo RC | title = Evidence for exposure to HTLV-III in Uganda before 1973 | journal = [[Science (journal)|Science]] | volume = 227 | issue = 4690 | pages = 1036–1038 | date = March 1985 | pmid = 2983417 | doi = 10.1126/science.2983417 | url = http://www.epiinformatics.com/ADPublications/HTLV1Antibodies.pdf | bibcode = 1985Sci...227.1036S }}</ref> | ||
Line 236: | Line 238: | ||
|- | |- | ||
| 2007 || May || Prevention || The World Health Organization and UNAIDS issue new guidance recommending “provider-initiated” HIV testing in healthcare settings. This is aimed to widen knowledge of HIV status and greatly increase access to HIV treatment and prevention.<ref name="HISTORY OF HIV AND AIDS OVERVIEW"/> | | 2007 || May || Prevention || The World Health Organization and UNAIDS issue new guidance recommending “provider-initiated” HIV testing in healthcare settings. This is aimed to widen knowledge of HIV status and greatly increase access to HIV treatment and prevention.<ref name="HISTORY OF HIV AND AIDS OVERVIEW"/> | ||
+ | |- | ||
+ | | 2007 || || || A breakthrough {{w|bone marrow}} transplant cures [[w:The Berlin Patient|Berlin patient]] Timothy Ray Brown, an HIV positive Californian living in Germany.<ref>{{cite book |title=How AIDS Ends: An Anthology from San Francisco AIDS Foundation |edition=San Francisco AIDS Foundation, Timothy Ray Brown, Jeanne White Ginder, Cleve Jones, Barbara Lee, Paul Farmer, Robert Gallo, Diane Havlir, Eduardo Xol, Hank Plante, LZ Granderson, Mark Dybul, Mervyn Silverman, Scott Wiener, Neil Giuliano |url=https://books.google.com.ar/books?id=gTBWDQAAQBAJ&pg=PT75&dq=In+2007,+Timothy+Ray+Brown&hl=en&sa=X&ved=0ahUKEwid59yEw7DbAhXJGpAKHSwQCJYQ6AEIKDAA#v=onepage&q=In%202007%2C%20Timothy%20Ray%20Brown&f=false}}</ref><ref>{{cite book |last1=Weeks |first1=Benjamin S. |last2=Shors |first2=Teri |title=AIDS: the Biological Basis |url=https://books.google.com.ar/books?id=_lv5XmlZ0n4C&pg=PA243&dq=In+2007,+Timothy+Ray+Brown&hl=en&sa=X&ved=0ahUKEwid59yEw7DbAhXJGpAKHSwQCJYQ6AEILzAB#v=onepage&q=In%202007%2C%20Timothy%20Ray%20Brown&f=false}}</ref> | ||
|- | |- | ||
| 2010 || January || Policy || The travel ban preventing HIV-positive people from entering the United States is lifted.<ref name="HISTORY OF HIV AND AIDS OVERVIEW"/> | | 2010 || January || Policy || The travel ban preventing HIV-positive people from entering the United States is lifted.<ref name="HISTORY OF HIV AND AIDS OVERVIEW"/> |
Revision as of 11:11, 31 May 2018
This is a timeline of HIV/AIDS, attempting to describe important events in the history of the virus and the disease.
Contents
Big picture
Time period | Development summary |
---|---|
1960s | Experts suggest that about 2,000 people in Africa may have been infected with HIV during this decade. Stored blood samples from an American malaria research project carried out in the Congo in 1959 prove one such example of early HIV infection.[1] The 1960s and the following decade are known as the “silent” decades as it is likely that HIV already circulated sometime during these times but was unknown or not reported. The spread would start in 1970’s when the medical community becomes aware.[2] |
1970s | The first epidemic of HIV/AIDS is believed to have occurred in Kinshasa. The emerging epidemic in the Congolese capital is signalled by a surge in opportunistic infections, such as cryptococcal meningitis, Kaposi’s sarcoma, tuberculosis and specific forms of pneumonia. It is speculated that HIV is brought to the city by an infected individual who travelled from Cameroon by river down into the Congo. On arrival in Kinshasa, the virus would enter a wide urban sexual network and spread quickly, giving riseto the world’s first heterosexually-spread HIV epidemic.[1] |
1980s | AIDS crisis decade, starting with the acknowledgement of a new epidemics in the United States. From 1981 through 1987, the average life expectancy for people diagnosed with AIDS is 18 months.[3] HIV begins its spread in Asia in the early to mid-1980s.[3] |
1990s-2000s | Introduction of antiretroviral medications halts the epidemic of AIDS in the United States.[4] Sub Saharan Africa becomes the hub of the HIV epidemic.[1] |
Full timeline
Year | Month and date | Event type | Details |
---|---|---|---|
1920s | According to scientists, the origin of AIDS pandemic may be traced to this decade in the city of Kinshasa, in what is now the Democratic Republic of Congo.[5] | ||
1930 | Infection | A complex computer model of the evolution of HIV-1 suggests that the first transfer of simian immunodeficiency virus (SIV) to humans occur around that year.[1] | |
1940s | Infection | HIV-2 transferral from monkeys to humans in Guinea-Bissau is calculated at some point in the decade.[1] | |
1959 | Infection | Early documented HIV-1 infection is discovered in a preserved blood sample taken in 1959 from a man from Léopoldville in the Belgian Congo.[6] | |
1960 | Infection | A second early documented HIV-1 infection is discovered in a preserved lymph node biopsy sample taken in 1960 from a woman from Léopoldville, Belgian Congo.[7] | |
1969 | May | Notable death | 16-year-old African-American Robert Rayford dies at the St. Louis City Hospital from Kaposi's sarcoma. In 1987 researchers at Tulane University School of Medicine would detect "a virus closely related or identical to" HIV-1 in his preserved blood and tissues.[8][9][10][11] |
1971 | Test | The enzyme-linked immunosorbent assay (ELISA) is introduced by Swedish immunologist Peter Perlmann and Eva Engvall at Stockholm University in Sweden, as a test that uses antibodies and color change to identify a substance. ELISA would later be used for the detection of HIV antibodies in blood samples.[12][13][14] | |
1972–1973 | Infection | Researchers draw blood from 75 children in Uganda to serve as controls for a study of Burkitt's lymphoma. In 1985, retroactive testing of the frozen blood serum indicate that antibodies to a virus related to HIV are present in 50 of the children.[15] | |
1975–1976 | Infection | Norwegian sailor Arvid Noe, his wife, and his seven-year-old daughter die of AIDS. The sailor first presented symptoms in 1969, eight years after he first spent time in ports along the West African coastline. A gonorrhea infection during his first African voyage shows he was sexually active at this time. Tissue samples from the sailor and his wife were tested in 1988 and found to contain HIV-1 (Group O).[16][17] | |
1979 | Test | Western blot is introduced as a method for protein analysis. Since then, it would become an essential assay for protein researchers, and it would be used to confirm ELISA results.[18][19][20] | |
1981 | June 5 | Publication | The U.S. Centers for Disease Control and Prevention (CDC) publishes a Morbidity and Mortality Weekly Report (MMWR), describing cases of a rare lung infection, Pneumocystis carinii pneumonia (PCP), in five young, previously healthy, men who have sex with men in Los Angeles.[21] |
1981 | July 3 | Epidemiology | The New York Times reports an outbreak of opportunistic infections and Kaposi's sarcoma among previously healthy men who have sex with men in New York and California.[22][23] |
1981 | December | Epidemiology | The first cases of PCP are reported in people who inject drugs.[24] |
1982 | January | Hospital | The first AIDS clinic in the United States is established in San Francisco.[25] |
1982 | Scientific development | The disease is given several names such as lymphadenopathy (as it causes swelling of lymph glands), gay compromise syndrome and for the popular press, “gay plague”. However, many of the patients are haemophiliacs.[2] | |
1982 | June | Epidemiology | A group of cases among men who have sex with men in Southern California suggests that the cause of the immune deficiency is sexual and the syndrome is initially called gay-related immune deficiency (GRID). Later that month, the disease is reported in haemophiliacs and Haitians leading many to believe it has originated in Haiti.[24][26] |
1982 | September 24 | Scientific development | The Centers for Disease Control and Prevention uses the term 'AIDS' (acquired immune deficiency syndrome) for the first time, describing it as "a disease at least moderately predictive of a defect in cell mediated immunity, occurring in a person with no known case for diminished resistance to that disease."[24][22][27] |
1983 | Epidemiology | Blood specimens show a 16 percent infection rate among tested gay men in Johannesburg. The small-scale epidemic is largely confined to white gay men and remains virtually unheard of in the general population in the mid–decade. The homosexual epidemic would stop growing by the end of the 1980s.[1] | |
1983 | February | Scientific development | American biomedical researcher Robert Gallo, from the National Institutes of Health, suggests that a retrovirus probably causes AIDS.[25] |
1983 | January 7 | Epidemiology | The Centers for Disease Control and Prevention reports cases of AIDS in female sexual partners of males with AIDS.[2][28] |
1983 | January | Epidemiology | AIDS is reported among the female partners of men who had the disease, suggesting it could be passed on via heterosexual sex.[24] |
1983 | May | Virology | French virologist rançoise Barré-Sinoussi and her colleagues at the Pasteur Institute in France report the discovery of a new retrovirus called Lymphadenopathy-Associated Virus (or LAV) that could be the cause of AIDS.[24][29] |
1983 | June | Epidemiology | The first reports of AIDS in children hints that it could be passed via casual contact but later it is concluded that they have probably directly acquired AIDS from their mothers before, during or shortly after birth.[24] |
1983 | September | Scientific development | The CDC identifies all major routes of transmission and rules out transmission by casual contact, food, water, air or surfaces.[24] |
1983 | November | Organization | The World Health Organization (WHO) holds its first meeting to assess the global AIDS situation and begins international surveillance.[24] |
1983 | December | Epidemiology | The number of AIDS cases in the United States rises to 3,064 with 1,292 deaths.[24] |
1983–1987 | Policy | President Mobutu of the Congo bans the subject of AIDS from the press for four years. Around the same time, Zimbabwean doctors are instructed not to mention AIDS on death certificates.[1] | |
1984 | Infection | The first patient in Thailand with AIDS is reported.[30] | |
1984 | April | Virology | The National Cancer Institute announces they have found the cause of AIDS, the retrovirus HTLV-III. In a joint conference with the Pasteur Institute they announce that LAV and HTLV-III are identical and the likely cause of the disease.[24] |
1984 | July | Prevention | The Centers for Disease Control and Prevention states that avoiding injecting drug use and sharing needles "should also be effective in preventing transmission of the virus.[24][31] |
1984 | October | Policy | Bath houses and private sex clubs in San Francisco are closed due to high-risk sexual activity. New York and Los Angeles would follow suit within a year.[24] |
1984 | December | Epidemiology | There have been 7,699 AIDS cases and 3,665 AIDS deaths in the USA with 762 cases reported in Europe. (Cumulative or only in 1984?).[24] |
c.1985 | Epidemiology | The Western African nation of Guinea-Bissau has the world’s highest level of HIV-2, with 26% of paid blood donors, 8.6% of pregnant women and 36.7% of sex workers testing positive. The virus spreads into rural areas of southern Senegal and Gambia but HIV-2 is not infectious enough to generate an epidemic beyond this region.[1] | |
1985 | Virology | Another retrovirus of the HIV family is isolated from persons living in West Africa.[22] | |
1985 | March | Medical development | The United States Food and Drug Administration licenses the first commercial blood test, ELISA, to detect antibodies to the virus. Blood banks begin to screen the USA blood supply.[32][24] |
1985 | April | Organization | The United States Department of Health and Human Services (HHS) and the World Health Organization host the first International AIDS Conference in Atlanta.[24] |
1985 | October 2 | Notable death | American actor Rock Hudson dies from AIDS, and leaves $250,000 to set up the American Foundation for AIDS Research (amfAR). Hudson is considered the first high profile AIDS fatality in the United States.[24] |
1985 | December | Epidemiology | Every region in the world has reported at least one case of AIDS, with 20,303 cases in total.[24] |
1985 | Virology | LAV and HTLV-3 are shown to be the same virus.[2] | |
1986 | Prevention | A prevention program is launched in Uganda. By this time the country is in the midst of a major epidemic, with a prevalence rate of 26% in its capital city.[24] | |
1986 | May | Scientific development | The International Committee on the Taxonomy of Viruses declares that the virus that causes AIDS will officially be known as Human Immunodeficiency Virus (HIV). |
1986 | May | Virology | The International Committee on the Taxonomy of Viruses says that the virus that causes AIDS will officially be called HIV (human immunodeficiency virus) instead of HTLV-III/LAV.[25][24] |
1986 | Prevention | The first United Kingdom government AIDS awareness campaign begins and is called “Don’t aid AIDS”.[2] | |
1987 | Prevention | The Ugandan AIDS control program formulates a five-year plan with the assistance of the World Health Organization. The plan is later made a model for Africa and receives more than £20 million in donor funding.[1][3] | |
1987 | February | Prevention | The World Health Organization launches The Global Program on AIDS to raise awareness; generate evidence-based policies; provide technical and financial support to countries; conduct research; promote participation by NGOs; and promote the rights of people living with HIV.[24] |
1987 | March | Drug | The Unites States Food and Drug Administration approves the first antiretroviral drug, zidovudine (AZT), as treatment for HIV.[24][33] |
1987 | April | Diagnosis | The Unites States Food and Drug Administration approves the Western blot blood test kit, a more specific test for HIV antibodies.[25] |
1987 | May 31 | Organization | United States President Ronald Reagan makes his first public speech about AIDS and establishes a Presidential Commission on HIV.[25] |
1987 | July | Scientific development | The World Health Organization confirms that HIV could be passed from mother to child during breastfeeding.[24] |
1987 | October | AIDS becomes the first illness debated in the United Nations General Assembly.[24] | |
1987 | Drug | Azidothymidine (also known as zidovudine) is introduced in the United States as the first treatment for HIV.[34] | |
1988 | Epidemiology | The second highest prevalence rate of HIV in all of Africa is found on the Tanzam road linking Tanzania and Zambia. The disease moves further south through Malawi, Zambia, Mozambique, Zimbabwe and Botswana.[1] | |
1988 | April | Organization | The World Health Organization holds an International Consultation on Health Legislation and Ethics in the Fields of HIV/AIDS in Oslo, with the decision to advocate bringing down barriers between people who are infected and those who are not infected and placing actual barriers (e.g. condoms) between individuals and the virus.[35] |
1988 | December 1 | The World Health Organization declares 1st December as the first World AIDS Day.[24][2] | |
1989 | March | Epidemiology | 145 countries report 142,000 AIDS cases. However, the WHO estimates there war up to 400,000 cases worldwide.[24] |
1989 | June | Prevention | The CDC releases the first guidelines to prevent Pneumocystis pneumonia (PCP) - an opportunistic infection that is a major cause of death among people with AIDS.[24] |
1989 | July | Organization | The first international consultation on AIDS and human rights is organized by the United Nations Centre for Human Rights, in cooperation with the World Health Organization/GPA.[35] |
1989 | Epidemiology | By the end of the decade, the southern African countries of Malawi, Zambia, Zimbabwe and Botswana are on the verge of overtaking East Africa as the focus of the global HIV epidemic.[1] | |
1990 | June | The 6th International AIDS Conference in San Francisco protests against the United States's immigration policy which stopped people with HIV from entering the country. NGOs boycot the conference.[24] | |
1990 | July | Policy | The United States government enacts the Americans with Disabilities Act (ADA) which prohibits discrimination against those with disabilities including people living with HIV.[24] |
1990 | October | Drug | The Food and Drug Administration approves the use of zidovudine (AZT) to treat children with AIDS.[24] |
1991 | November | Notable death | British singer Freddie Mercury announces he has AIDS and dies a day later.[24] |
1991 | Drug | Dideoxycytidine (ddC), the third drug to slow progression of AIDS, is developed.[2] | |
1993 | March | Policy | The United States Congress votes overwhelmingly to retain the ban on entry into the country for people living with HIV.[24] |
1993 | Scientific development | The CDC adds pulmonary tuberculosis, recurrent pneumonia and invasive cervical cancer to the list of AIDS indicators.[24] | |
1993 | Resistance | The first resistance to Zidovudine by the HIV is reported.[2] | |
1993 | December | Epidemiology | There are an estimated 9 million people infected in the sub-Saharan region out of a global total of 14 million.[1] An estimated 2.5 million AIDS cases are reported globally in the year.[24] |
1994 | Drug | It is discovered that the antiretroviral drug zidovudine (AZT) could reduce mother-to-child transmission by two-thirds.[1][2] | |
1994 | February | Organization | The Asia-Pacific Network of people with HIV/ AIDS is established.[36] |
1994 | August | Drug | the United States Public Health Service recommends the use of AZT to prevent the mother-to-child transmission of HIV.[24] |
1994 | December | Diagnosis | The United States Food and Drug Administration approves an oral HIV test - the first non-blood HIV test.[24] |
1995 | June | Drug | The United States Food and Drug Administration approves the first protease inhibitor beginning a new era of highly active antiretroviral treatment (HAART). Once incorporated into clinical practice HAART would bring about an immediate decline of between 60% and 80% in rates of AIDS-related deaths and hospitalisation in those countries which could afford it.[24] |
1995 | Epidemiology | AIDS becomes the main cause of death in 25-44 age group in the United States.[2] | |
1995 | December | Epidemiology | There are an estimated 4.7 million new HIV infections worldwide - 2.5 million in southeast Asia and 1.9 million in sub-Saharan Africa.[24] |
1996 | January | Organization | The Joint United Nations Programme on AIDS (UNAIDS) is launched to advocate for global action on the epidemic and coordinate the response to HIV and AIDS across the United Nations.[24][37] |
1996 | December | Epidemiology | By the end of the year, the estimated number of people living with HIV is 23 million worldwide.[24] |
1997 | September | Drug | The United States Food and Drug Administration approves Combivir, a combination of two antiretroviral drugs, taken as a single daily tablet, making it easier for people living with HIV to take their medication.[24] |
1997 | Epidemiology | UNAIDS estimates that 30 million people have HIV worldwide equating to 16,000 new infections a day.[24] | |
1998 | Epidemiology | Sub-Saharan Africa is home to 70% of people who became infected with HIV during the year, with an estimated one in seven of these new infections occurring in South Africa.[1] | |
1998 | Drug | Glaxo Wellcome cuts the price of zidovudine AZT by 75%.[1] | |
1999 | Prevention | Botswana launches Africa’s first program to combat mother-to-child transmission.[1] | |
1999 | Epidemiology | The World Health Organization announces that AIDS is the fourth biggest cause of death worldwide and number one killer in Africa. An estimated 33 million people are estimated to live with HIV and 14 million people have died from AIDS since the start of the epidemic.[24] | |
1999 | Policy | The Kenyan President Daniel Arap Moi declares AIDS a national disaster.[1] | |
1999 | Virology | An international team of researchers reports having discovered the origins of HIV-1, the predominant strain of HIV in the developed world.[38] | |
2000 | July | UNAIDS negotiates with five pharmaceutical companies to reduce antiretroviral drug prices for developing countries.[24] | |
2000 | September | Program launch | The United Nations adopt the Millennium Development Goals which includes a specific goal to reverse the spread of HIV, malaria and tuberculosis.[24] |
2000 | Prevention | HIV Vaccine trials begin in Oxford.[2] | |
2000 | Epidemiology | About 34.3 million cases of HIV are estimated worldwide, with largest number in South Africa.[2] | |
2001 | February | Organization | The Pan-Caribbean Partnership Against HIV/AIDS (PANCAP) is established.[39] |
2001 | June | Program | The United Nations (UN) General Assembly calls for the creation of a "global fund" to support efforts by countries and organizations to combat the spread of HIV through prevention, treatment and care including buying medication.[24][1] |
2001 | November | Program | The World Trade Organization (WTO) announces the Doha Declaration, which allows developing countries to manufacture generic medications to combat public health crises like HIV.[24] |
2001 | Epidemiology | There are more than 20 million people (based on current estimates) living with AIDS in sub-Saharan Africa, but only 8,000 people have access to drug treatment.[1] | |
2002 | January | Organization | The Global Fund to Fight AIDS, Tuberculosis and Malaria begins operations. In April the Global Fund approves its first round of grants totalling US$600 million.[24][37] |
2002 | July | Epidemiology | UNAIDS reports that AIDS is already by far the leading cause of death in sub-Saharan Africa.[24] |
2002 | November | The United States Food and Drug Administration approves the first rapid HIV test with 99.6% accuracy and a result in 20 minutes.[24][34] | |
2003 | January | Organization | United States President George W. Bush announces the creation of the United States President's Emergency Plan for AIDS Relief (PEPFAR), a $15 billion, five-year plan to combat AIDS, primarily in countries with a high number of HIV infections.[24] |
2003 | June | Drug | Atazanavir is released as an antiretroviral medication for the treatment and prevention of HIV/AIDS.[40] |
2003 | October | Drug | Fosamprenavir is marketed for the treatment of HIV infections.[41] |
2003 | December | Program | The World Health Organization announces the “3 by 5” initiative to bring HIV treatment to 3 million people by 2005.[24] |
2004 | February | Organization | The Joint United Nations Programme on HIV/AIDS (UNAIDS) launches the Global Coalition on Women and AIDS, with the purpose of uniting civil society groups working on HIV, women, and gender equality.[42] |
2004 | February | Organization | China establishes the State Council Working Committee on HIV/AIDS, with the purpose of revamping and upgrading the former National Coordinating Committee on HIV/AIDS and Sexually Transmitted Diseases.[43] |
2004 | Secretary-General of the United Nations Kofi Annan prioritizes HIV/AIDS, stating, "AIDS is a new type of global emergency--an unprecedented threat to human development".[37] | ||
2004 | At the Copenhagen Consensus, a policy think tank in Denmark, a panel of eight prominent economists rank controlling HIV/AIDS as the number one economic priority in terms of a cost-benefit analysis in health and nutrition.[37] | ||
2005 | Drug companies and makers agree to make available cheaper generic anti-viral drugs.[2] | ||
2005 | June | Drug | Tipranavir is released for the treatment of HIV infection.[44] |
2006 | January | Epidemiology | The UNAIDS report estimates that 49% of new 2005 HIV infections were from sexual transmission, and that over 40% of those living with HIV in China were infected through sex.[45] |
2006 | Scientific development | Male circumcision is found to reduce the risk of female-to-male HIV transmission by 60%.[24] | |
2006 | Drug | Darunavir is released as an antiretroviral medication used to treat and prevent HIV/AIDS.[46] | |
2007 | May | Prevention | The World Health Organization and UNAIDS issue new guidance recommending “provider-initiated” HIV testing in healthcare settings. This is aimed to widen knowledge of HIV status and greatly increase access to HIV treatment and prevention.[24] |
2007 | A breakthrough bone marrow transplant cures Berlin patient Timothy Ray Brown, an HIV positive Californian living in Germany.[47][48] | ||
2010 | January | Policy | The travel ban preventing HIV-positive people from entering the United States is lifted.[24] |
2010 | July | The CAPRISA 004 microbicide trial is hailed a success after results show that the microbicide gel reduces the risk of HIV infection in women by 40%.[24] | |
2011 | August | Drug | The United States Food and Drug Administration approves Complera, the second all-in-one fixed dose combination tablet, expanding the treatment options available for people living with HIV.[24] |
2011 | December | Treatment | Antiretroviral therapy reaches 8 million people by the end of the year, a twenty-fold increase since 2003. For the first time, a majority (54%) of people eligible for antiretroviral therapy in low- and middle-income countries are receiving antiretroviral therapy.[49] |
2012 | July | Drug | The United States Food and Drug Administration approves PrEP for HIV-negative people to prevent the sexual transmission of HIV.[24] |
2013 | Epidemiology | UNAIDS reports that AIDS-related deaths fell from a high of 2.3 (2.1–2.6) million in 2005 to 1.6 (1.4–1.9) million in 2012.[50] | |
2015 | January 8 | Scientific development | A review of multiple studies of South African women indicates that using Depo Provera, an injectable contraceptive, may increase women’s chances of contracting HIV by 40%.[51] |
2015 | September | Treatment | The World Health Organization launches new treatment guidelines recommending that all people living with HIV should receive antiretroviral treatment, regardless of their CD4 count, and as soon as possible after their diagnosis.[24] |
2015 | November 30 | Organization | The Foundation for AIDS Research announces the establishment of the amfAR Institute for HIV Cure Research, a collaborative enterprise based at the University of California, San Francisco. The Institute is aimed at supporting teams of scientists working from basic science to clinical studies.[52] |
2016 | Epidemiology | The number of people in Russia living with HIV reaches one million. Newly released figures also show 64% of all new HIV diagnoses in Europe occurred in that country.[24] | |
2016 | January 28 | Drug resistance | Researchers announce a global epidemiology of drug resistance after international study of over 1,900 patients with HIV who failed to respond to the antiretroviral drug tenofovir—a key HIV treatment medication—indicates that HIV resistance to the medication is becoming increasingly common.[53] |
2016 | February 25 | At the annual Conference on Retroviruses and Opportunistic Infections (CROI), researchers report that a man taking the HIV-prevention drug Truvada (emtricitabine/tenofovir), has contracted HIV. This marks the first reported infection of someone regularly taking the drug.[54] | |
2016 | March 3 | Pharmacy researchers at the University of North Carolina at Chapel Hill report finding that women need daily doses of the antiviral medication emtricitabine/tenofovir to prevent HIV infection, while men only need two doses per week due to differences in the way the drug accumulates in vaginal, cervical and rectal tissue.[55] |
Meta information on the timeline
How the timeline was built
The initial version of the timeline was written by User:Sebastian.
Funding information for this timeline is available.
What the timeline is still missing
Timeline update strategy
See also
External links
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 "The History of AIDS in Africa". blackhistorymonth.org.uk. Retrieved 4 February 2018.
- ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 "History of AIDS". news-medical.net. Retrieved 4 February 2018.
- ↑ 3.0 3.1 3.2 "HIV/AIDS". healthcommunities.com. Retrieved 21 March 2018.
- ↑ "HIV in America: The Complicated Truth". esquire.com. Retrieved 30 April 2018.
- ↑ Gallagher, James. "Aids: Origin of pandemic 'was 1920s Kinshasa'". bbc.com. Retrieved 4 February 2018.
- ↑ Zhu, Tuofu; Korber, Bette T.; Nahmias, Andre J.; Hooper, Edward; Sharp, Paul M.; Ho, David D. "An African HIV-1 sequence from 1959 and implications for the origin of the epidemic". doi:10.1038/35400.
- ↑ Worobey, Michael; Gemmel, Marlea; Teuwen, Dirk E.; Haselkorn, Tamara; Kunstman, Kevin; Bunce, Michael; Muyembe, Jean-Jacques; Kabongo, Jean-Marie M.; Kalengayi, Raphaël M.; Van Marck, Eric; Gilbert, Thomas P.; Wolinsky, Steven M. "Direct Evidence of Extensive Diversity of HIV-1 in Kinshasa by 1960". PMC 3682493. doi:10.1038/nature07390.
- ↑ Garry RF, Witte MH, Gottlieb AA, Elvin-Lewis M, Gottlieb MS, Witte CL, Alexander SS, Cole WR, Drake WL (October 1988). "Documentation of an AIDS virus infection in the United States in 1968". JAMA. 260 (14): 2085–7. PMID 3418874. doi:10.1001/jama.1988.03410140097031.
- ↑ Haislip AM, Witte MH, Sullivan KA, Wolfe M, Gottlieb AA, Gottlieb MS, Cole WR, Witte CL, Garry RF. "The Earliest Known AIDS Patient in the United States was Infected with an HIV-1 Strain Closely Related to IIIB/LAI". XIth International Congress of Virology, Sydney Convention Center, Australia, 9–13 August 1999. Archived from the original on 2007-04-15.
- ↑ "Epidemiology of HIV/AIDS in the United States". ucsf.edu. Retrieved 21 March 2018.
- ↑ Kolata, Gina (1987-10-28). "Boy's 1969 death suggests AIDS invaded U.S. Several times". The New York Times.
- ↑ Corley, Ronald B. A Guide to Methods in the Biomedical Sciences.
- ↑ Owusu-Apenten, Richard. Food Protein Analysis: Quantitative Effects On Processing.
- ↑ "ELISA- Principle, Types and Applications". microbiologynotes.com. Retrieved 31 May 2018.
- ↑ Saxinger WC, Levine PH, Dean AG, de Thé G, Lange-Wantzin G, Moghissi J, Laurent F, Hoh M, Sarngadharan MG, Gallo RC (March 1985). "Evidence for exposure to HTLV-III in Uganda before 1973" (PDF). Science. 227 (4690): 1036–1038. Bibcode:1985Sci...227.1036S. PMID 2983417. doi:10.1126/science.2983417.
- ↑ Frøland SS, Jenum P, Lindboe CF, Wefring KW, Linnestad PJ, Böhmer T (June 1988). "HIV-1 infection in Norwegian family before 1970". Lancet. 1 (8598): 1344–5. PMID 2897596. doi:10.1016/S0140-6736(88)92164-2.
- ↑ Hooper E (1997). "Sailors and star-bursts, and the arrival of HIV". BMJ. 315 (7123): 1689–91. PMC 2128008. PMID 9448543. doi:10.1136/bmj.315.7123.1689.
- ↑ "The Western Blot: A General Overview". advansta.com. Retrieved 31 May 2018.
- ↑ "Western blot". proteinatlas.org. Retrieved 31 May 2018.
- ↑ "Western blot". medical-dictionary.thefreedictionary.com. Retrieved 31 May 2018.
- ↑ "Pneumocystis Pneumonia --- Los Angeles". Retrieved 21 March 2018.
- ↑ 22.0 22.1 22.2 Ansary, M. A. A Colour Atlas of AIDS in the Tropics.
- ↑ ALTMAN, LAWRENCE K. "RARE CANCER SEEN IN 41 HOMOSEXUALS". nytimes.com. Retrieved 21 March 2018.
- ↑ 24.00 24.01 24.02 24.03 24.04 24.05 24.06 24.07 24.08 24.09 24.10 24.11 24.12 24.13 24.14 24.15 24.16 24.17 24.18 24.19 24.20 24.21 24.22 24.23 24.24 24.25 24.26 24.27 24.28 24.29 24.30 24.31 24.32 24.33 24.34 24.35 24.36 24.37 24.38 24.39 24.40 24.41 24.42 24.43 24.44 24.45 24.46 24.47 24.48 24.49 24.50 24.51 24.52 24.53 24.54 24.55 24.56 24.57 24.58 "HISTORY OF HIV AND AIDS OVERVIEW". avert.org. Retrieved 3 February 2018.
- ↑ 25.0 25.1 25.2 25.3 25.4 "A Timeline of HIV and AIDS". hiv.gov. Retrieved 21 March 2018.
- ↑ "Epidemiologic Notes and Reports Pneumocystis carinii Pneumonia among Persons with Hemophilia A". cdc.gov. Retrieved 4 February 2018.
- ↑ "Current Trends Update on Acquired Immune Deficiency Syndrome (AIDS) --United States". cdc.gov. Retrieved 21 March 2018.
- ↑ "Epidemiologic Notes and Reports Immunodeficiency among Female Sexual Partners of Males with Acquired Immune Deficiency Syndrome (AIDS) -- New York". cdc.gov. Retrieved 21 March 2018.
- ↑ Barré-Sinoussi, F; Chermann, JC; Rey, F; Nugeyre, MT; Chamaret, S; Gruest, J; Dauguet, C; Axler-Blin, C; Vézinet-Brun, F; Rouzioux, C; Rozenbaum, Rozenbaum; Montagnier, L. "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).". PMID 6189183.
- ↑ "The WORLD HEALTH REPORT 1999" (PDF). who.int. Retrieved 4 February 2018.
- ↑ "Antibodies to a Retrovirus Etiologically Associated with Acquired Immunodeficiency Syndrome (AIDS) in Populations with Increased Incidences of the Syndrome". cdc.gov. Retrieved 21 March 2018.
- ↑ Smith, Raymond A. Encyclopedia of AIDS: A Social, Political, Cultural, and Scientific Record of the HIV Epidemic.
- ↑ Tan, W. Y. Stochastic Modeling of AIDS Epidemiology and HIV Pathogenesis.
- ↑ 34.0 34.1 "The History of HIV and AIDS in the United States". healthline.com. Retrieved 8 May 2018.
- ↑ 35.0 35.1 International Guidelines on HIV/AIDS and Human Rights: Second International Consultation on HIV/AIDS and Human Rights, Geneva, 23-25 September 1996, Third International Consultation on HIV/AIDS and Human Rights : Geneva, 25-26 July 2002. United Nations. Office of the High Commissioner for Human Rights, Joint United Nations Programme on HIV/AIDS.
- ↑ 1st Pacific Regional HIV/AIDS and STD Conference, 23-25 February 1999. Secretariat of the Pacific Community, 1999 - AIDS (Disease).
- ↑ 37.0 37.1 37.2 37.3 Smith, Julia H; Whiteside, Alan. "The history of AIDS exceptionalism". PMC 3004826. PMID 21129197. doi:10.1186/1758-2652-13-47.
- ↑ "Where did HIV come from?". theaidsinstitute.org. Retrieved 30 April 2018.
- ↑ Kelly,, Michael J.; Bain, Brendan. Education and HIV/AIDS in the Caribbean.
- ↑ "Efectos adversos de atazanavir - Elsevier". elsevier.es. Retrieved 8 May 2018.
- ↑ "Fosamprenavir (Lexiva, Telzir)". hivinsite.ucsf.edu. Retrieved 8 May 2018.
- ↑ Müller, Tanja R. HIV/AIDS, Gender and Rural Livelihoods in Sub-Saharan Africa: An Overview and Annotated Bibliography.
- ↑ HIV/AIDS in Asia: Hearing Before the Subcommittee on Asia and the Pacific of the Committee on International Relations, House of Representatives, One Hundred Eighth Congress, Second Session, July 21, 2004, Volume 4. United States. Congress. House. Committee on International Relations. Subcommittee on Asia and the Pacific U.S. Government Printing Office, Jan 1, 2004 - AIDS (Disease).
- ↑ "Tipranavir (Aptivus)". hivinsite.ucsf.edu. Retrieved 8 May 2018.
- ↑ Gender Policy and HIV in China: Catalyzing Policy Change (by Joseph Tucker, Dudley L. Poston, Jr., Qiang Ren, Baochang Gu, Xiaoying Zheng, Stephanie Wang, Chris Russell ed.).
- ↑ "Darunavir (Prezista)". hivinsite.ucsf.edu. Retrieved 8 May 2018.
- ↑ How AIDS Ends: An Anthology from San Francisco AIDS Foundation (San Francisco AIDS Foundation, Timothy Ray Brown, Jeanne White Ginder, Cleve Jones, Barbara Lee, Paul Farmer, Robert Gallo, Diane Havlir, Eduardo Xol, Hank Plante, LZ Granderson, Mark Dybul, Mervyn Silverman, Scott Wiener, Neil Giuliano ed.).
- ↑ Weeks, Benjamin S.; Shors, Teri. AIDS: the Biological Basis.
- ↑ "The treatment gap in lowand middle-income countries" (PDF). unaids.org. Retrieved 4 February 2018.
- ↑ "GLOBAL REPORT" (PDF). files.unaids.org. Retrieved 4 February 2018.
- ↑ Ralph, Lauren J; McCoy, Sandra I; Shiu, Karen; Padian, Nancy S. "Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies".
- ↑ "amfAR Establishes San Francisco-Based Institute for HIV Cure Research". amfar.org. Retrieved 21 March 2018.
- ↑ "Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study". The TenoRes Study Group.
- ↑ "HIV-1 Infection With Multiclass Resistance Despite Preexposure Prophylaxis (PrEP)". croiconference.org. Retrieved 21 March 2018.
- ↑ "Women need more of the HIV drug Truvada than men to prevent infection". uncnews.unc.edu. Retrieved 21 March 2018.